Atrial fibrillation (AF) is associated with significant morbidity and mortality. It is also a
progressive disease secondary to continuous structural remodelling of the atria due to AF …

There has been sustained focus on the secondary prevention of coronary heart disease and
heart failure; yet, apart from stroke prevention, the evidence base for the secondary …

Atrial fibrillation (AF) is the most common sustained clinical arrhythmia, with a lifetime
incidence of up to 37%, and is a major contributor to population morbidity and mortality …

Atrial fibrillation (AF) is among the most common cardiac arrhythmias and its prevalence is
still on the rise [1, 2]. Over the past decades, the proportion of ischemic strokes attributable to …

Atrial fibrillation (AF) is the most common sustained heart rhythm disorder and is associated
with substantial morbidity and mortality. Current treatment options for AF have significant …

Atrial fibrillation (AF), as the most common cardiac arrhythmia worldwide, is associated with
increased mortality and morbidity. Successful therapeutic strategies have been introduced …

Over time, atrial fibrillation (AF) naturally progresses from initially paroxysmal to
persistent/permanent AF caused by structural and electrical remodelling with a complex …

The fundamental mechanisms governing the perpetuation of atrial fibrillation (AF), the most
common arrhythmia seen in clinical practice, are poorly understood, which explains in part …

Since the clinical use of digitalis as the first pharmacological therapy for atrial fibrillation (AF)
235 years ago in 1785, antiarrhythmic drug therapy has advanced considerably and …

Atrial fibrillation (AF) is the most common arrhythmia diagnosed in clinical practice. The
consequences of AF have been clearly established in multiple large observational cohort …